The U.S. Department of Health and Human Services also announced it would give $450 million to the biotech company Regeneron to manufacture and supply Policy and Legislation By Kat Jercich | July 7, 2020 | 5:17 PM Topic: Accounting & Financial Management, Policy and Legislation, Population Health